Incyte retweeted
Alopecia areata is an autoimmune disease that can cause devastating hair loss; there are no approved medicines. Learn about late-breaking clinical trial results for a potential treatment being studied for AA: e.lilly/3iEKNTQ #AAD22
Incyte retweeted
JUST IN: An update about our randomized, placebo-controlled trial studying a Lilly medicine as a potential #COVID19 treatment for hospitalized patients. Learn more: e.lilly/3dN4Mwz
NORD is proud to announce this year's rare heroes -- the 2021 #RareImpact Award honorees. Read the press release on our blog: bit.ly/3kiNYAp (1/3)
Incyte retweeted
New: Lilly and @Incyte are sharing additional data showing reduced time to recovery and improved clinical outcomes for patients with #COVID19 infection requiring oxygen. Learn more: e.lilly/30OG4qe
Incyte retweeted
FDA granted Priority Review to investigational treatment for patients with a specific mutation in advanced non-small cell lung cancer. #NovartisNews #NSCLC
Incyte retweeted
This September, participate in the #MyMPNChallenge to take action and support the #MPN patient community! For every challenge completed, @Incyte will make a donation to @LLSusa.
Incyte retweeted
Herve Hoppenot, President & CEO of #DEBIO member company @Incyte, provides an inside look at the #technology & #innovation happening at the #Delaware based #pharmaceutical #research facility!
Incyte retweeted
Thankful for @Incyte for being part of our Vitiligo nation💜
Director of @vrfoundation, Yan Valle, shares a rallying cry for people to get involved on #WVD2019 to ensure the community’s voices are being heard. Visit 25june.org/ to add your voice & help spread awareness.
Incyte retweeted
.@Incyte is dedicated to conducting the research process. We are discovering new products that help patients with cancer. - Hervé Hoppenot, President & CEO of @Incyte. #GreaterHere #BIO2019 #TalentResearchResultsPHL – at Philadelphia, PA
#Innovation takes more than resources and more than time, it’s also the ability to let the science take you where it belongs - Hervé Hoppenot, President & CEO of @Incyte #BIO2019 #TalentResearchResultsPHL #HealthCarePHL
Incyte retweeted
#Delaware in the house at the #WHSTEMSummit @NSF today. @DEDeptofEd @zipcodewilm @Incyte wonderful to share ideas and insights together! #discourse #paemst adventures
Incyte retweeted
“For the future of #science and #STEM, it is critical to think about the integration we are talking about here, with technology that intersects with people’s lives and with their work.” - NSF COO Joan Ferrini-Mundy at #WHSTEMSummit
Incyte retweeted
Register now to receive educational resources, awareness ribbons, and bracelets to help spread awareness about myelofibrosis (MF): mfstateofmine.com
Incyte retweeted
A #Conversation With #STEM #LEADERS is taking place with Paula Swain of @Incyte , Donna Fontana of @Fidelity , Adele Gulfo of @MylanNews , and Rose Lee of @DuPont_News. @DESCAlliance @InspiringSTEM #IWSTEM
Incyte retweeted
New #RheumatoidArthritis treatment in partnership with @Incyte approved by @US_FDA: elil.ly/vlp1 #FDAapproval
Incyte retweeted
Register now to receive educational resources, awareness ribbons, and bracelets to help spread awareness about myelofibrosis (MF): mfstateofmine.com
Incyte retweeted
Voices of MPN is an educational and awareness resource for people living with myeloproliferative neoplasms (MPNs). Join the conversation!
Incyte retweeted
Special thanks to CEO of @Incyte Hervé Hoppenot, Institute Director of @NIIMBL Kelvin Lee and Associate @mccarterenglish Philip Amoa for joining us tonight for a special Fireside Chat #DEBioGala #IgnitingInnovation – at Delaware, USA
























